BGI Offer for Complete Genomics Extended Until March 1 | GenomeWeb
Home » BGI Offer for Complete Genomics Extended Until March 1

BGI Offer for Complete Genomics Extended Until March 1

Feb 25, 2013
|
a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BGI said after the close of the market on Friday it has again extended its cash tender offer for Complete Genomics.

The $118 million deal is now set to expire at midnight ET on March 1. The offer has been pushed back several times and most recently was to expire at midnight Feb. 22.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Nov 23, 2015

BGI Halts Revolocity Launch, Cuts Complete Genomics Staff as Part of Strategic Shift

May 18, 2016

Q&A: Mao Mao, New Chief Scientific Officer of BGI Genomics, on Developing Clinical Genetic Tests

Premium
Dec 28, 2015

Technology Improvements, Long Reads Lead NGS Market Advancements in 2015

Premium
Sep 01, 2016

As Exome Sequencing in Diagnostics Becomes Routine, Dutch Clinical Lab Sees Future in Whole Genomes

Premium
Oct 26, 2015

BGI Launches Desktop Sequencer in China; Plans to Register Platform With CFDA

Premium
Dec 02, 2015

Complete Genomics Laying off 186 Employees

The Scan

This Week in Science

In Science this week: global genetic diversity map, and more.

To Follow Up On

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

Look into the (Possible) Future

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Urged to Amend

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

What's Popular?

In Clinical Sequencing

  1. BARDA Awards $51.9M to DNAe to Develop Rapid Diagnostics

  2. Sure Genomics Gets FDA Letter

  3. NIPT Outperforms Standard Screening for T21 but False Positives Call for Caution, NEJM Studies Find

  4. Cannabis Sequencing Study Explores Differences Between Marijuana, Hemp Producing Plants

  5. Roche Shutting Down 454 Sequencing Business

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.